Prognostic Significance of a Combination of Soluble Fas and Soluble Fas Ligand in the Serum of Patients with Ta Bladder Cancer
Authors:
- 1 October 2002
- journal article
- research article
- Published by SAGE Publications in Cancer Biotherapy and Radiopharmaceuticals
- Vol. 17 (5) , 563-567
Abstract
Recurrence after transurethral resection is one of the major problems in the treatment of superficial bladder cancer. However, there are no potent prognostic markers for recurrence in superficial bladder cancer at present. As circulating soluble Fas (sFas) and soluble Fas ligand (sFasL) have been implicated in protection from Fas-mediated apoptosis against cancers and may interfere with immune surveillance against autologous cancers, sFas and sFasL in the serum of patients with Ta bladder cancer were evaluated as prognostic tumor markers for recurrence. The serum levels of sFas and sFasL were measured by an enzyme-linked immunosorbent assay. Patients with Ta bladder cancer with low serum levels of both sFas and sFasL had a significantly longer postoperative tumor-free interval than those with high serum level of either sFas or sFasL in the 3-year follow-up. There was no correlation between the serum levels of sFas and sFasL. The present study has demonstrated that elevated serum sFas or sFasL predicts early recurrence in patients with Ta bladder cancer. These findings suggest that the serum levels of sFas and sFasL can be used as a prognostic indicator for recurrence in patients with Ta bladder cancer, and that sFas and sFasL may independently inhibit Fas-mediated apoptosis.Keywords
This publication has 17 references indexed in Scilit:
- Significance of serum soluble fas ligand in patients with bladder carcinomaCancer, 2001
- Not so Fas: Re-evaluating the mechanisms of immune privilege and tumor escapeNature Medicine, 2000
- PROGNOSTIC SIGNIFICANCE OF SOLUBLE FAS IN THE SERUM OF PATIENTS WITH BLADDER CANCERJournal of Urology, 1998
- Fas ligand in human serumNature Medicine, 1996
- Metalloproteinase-mediated release of human Fas ligand.Journal of Experimental Medicine, 1995
- The Fas Death FactorScience, 1995
- Fas-mediated cytotoxicity by freshly isolated natural killer cells.Journal of Experimental Medicine, 1995
- Fas and Perforin Pathways as Major Mechanisms of T Cell-Mediated CytotoxicityScience, 1994
- Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor familyCell, 1993
- The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosisCell, 1991